Menin–MLL1 Interaction Small Molecule Inhibitors: A Potential Therapeutic Strategy for Leukemia and Cancers
Encoded by the <i>MEN1</i> gene, menin protein is a fusion protein that is essential for the oncogenic transformation of mixed-lineage leukemia (MLL) and leads to acute leukemia (AL). Therefore, accumulating evidence has demonstrated that inhibition of the high-affinity relationship betw...
Main Authors: | Qing Shi, Meiqi Xu, Zhijian Kang, Manjie Zhang, Yakun Luo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/28/7/3026 |
Similar Items
-
Research progress in Menin-MLL interaction and its inhibitors in MLL-rearranged leukemia
by: FANG Xinyue, et al.
Published: (2024-10-01) -
Menin inhibitors for the treatment of acute myeloid leukemia: challenges and opportunities ahead
by: Kalyan V. G. Nadiminti, et al.
Published: (2024-11-01) -
Menin inhibitors for acute myeloid leukemia: latest updates from the 2023 ASH Annual Meeting
by: Zhuo-Yu An, et al.
Published: (2024-07-01) -
A 2024 Update on Menin Inhibitors. A New Class of Target Agents against KMT2A-Rearranged and NPM1-Mutated Acute Myeloid Leukemia
by: Anna Candoni, et al.
Published: (2024-04-01) -
Small Molecule Menin Inhibitors: Novel Therapeutic Agents Targeting Acute Myeloid Leukemia with KMT2A Rearrangement or NPM1 Mutation
by: Xavier Thomas
Published: (2024-02-01)